| scholarly article | Q13442814 |
| P356 | DOI | 10.1586/14737175.2014.864952 |
| P698 | PubMed publication ID | 24320602 |
| P50 | author | Jonatan Salzer | Q42241155 |
| P2093 | author name string | Peter Sundström | |
| Martin Biström | |||
| P2860 | cites work | Efficacy of vitamin D supplementation in multiple sclerosis (EVIDIMS Trial): study protocol for a randomized controlled trial | Q21203734 |
| ‘Mendelian randomization’: can genetic epidemiology contribute to understanding environmental determinants of disease?* | Q22066036 | ||
| A systematic review of randomized, double-blind, placebo-controlled trials examining the clinical efficacy of vitamin D in multiple sclerosis | Q22241932 | ||
| Evaluation, Treatment, and Prevention of Vitamin D Deficiency: an Endocrine Society Clinical Practice Guideline | Q22306207 | ||
| Common genetic determinants of vitamin D insufficiency: a genome-wide association study | Q24602058 | ||
| The VITamin D and OmegA-3 TriaL (VITAL): rationale and design of a large randomized controlled trial of vitamin D and marine omega-3 fatty acid supplements for the primary prevention of cancer and cardiovascular disease | Q24613094 | ||
| Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis | Q24635370 | ||
| 25-hydroxyvitamin D levels and the risk of mortality in the general population | Q24650811 | ||
| Vitamin D deficiency | Q27860616 | ||
| Intake of vitamin D and risk of type 1 diabetes: a birth-cohort study | Q28204926 | ||
| Causal relationship between obesity and vitamin D status: bi-directional Mendelian randomization analysis of multiple cohorts | Q28709200 | ||
| Association between pre-diagnostic circulating vitamin D concentration and risk of colorectal cancer in European populations:a nested case-control study | Q28749202 | ||
| A Reverse J-Shaped Association of All-Cause Mortality with Serum 25-Hydroxyvitamin D in General Practice: The CopD Study | Q29030051 | ||
| Multiple sclerosis | Q29616022 | ||
| Plasma vitamin D and mortality in older men: a community-based prospective cohort study | Q33447581 | ||
| Genome-wide association study of circulating vitamin D levels | Q33904451 | ||
| Vitamin effects on the immune system: vitamins A and D take centre stage | Q34005584 | ||
| Influence of season and latitude on the cutaneous synthesis of vitamin D3: exposure to winter sunlight in Boston and Edmonton will not promote vitamin D3 synthesis in human skin | Q34048074 | ||
| Vitamin D intake and incidence of multiple sclerosis | Q34289402 | ||
| Effect of vitamin D3 supplementation on upper respiratory tract infections in healthy adults: the VIDARIS randomized controlled trial | Q34303576 | ||
| Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis | Q34573482 | ||
| Vitamin D deficiency and risk of cardiovascular disease | Q34586829 | ||
| Vitamin D status predicts new brain magnetic resonance imaging activity in multiple sclerosis | Q34641782 | ||
| Critique of the U-shaped serum 25-hydroxyvitamin D level-disease response relation | Q34974606 | ||
| The initiation and prevention of multiple sclerosis | Q35741861 | ||
| Effect on the incidence of pneumonia of vitamin D supplementation by quarterly bolus dose to infants in Kabul: a randomised controlled superiority trial | Q35947636 | ||
| Vitamin D receptor binding, chromatin states and association with multiple sclerosis. | Q36122415 | ||
| No evidence of association between mutant alleles of the CYP27B1 gene and multiple sclerosis | Q36780814 | ||
| Vitamin D as an immune modulator in multiple sclerosis, a review | Q37051712 | ||
| Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis | Q37322100 | ||
| Dose-related effects of vitamin D on immune responses in patients with clinically isolated syndrome and healthy control participants: study protocol for an exploratory randomized double- blind placebo-controlled trial | Q37351726 | ||
| Environmental factors and their timing in adult-onset multiple sclerosis | Q37692820 | ||
| Effect of vitamin D supplementation on progression of knee pain and cartilage volume loss in patients with symptomatic osteoarthritis: a randomized controlled trial | Q37700057 | ||
| The changing demographic pattern of multiple sclerosis epidemiology | Q37732614 | ||
| Modulation of the immune system by UV radiation: more than just the effects of vitamin D? | Q37919719 | ||
| Vitamin D and child health part 1 (skeletal aspects). | Q38071499 | ||
| Current recommendations for multiple sclerosis treatment in pregnancy and puerperium. | Q38125249 | ||
| Efficacy of vitamin D3 as add-on therapy in patients with relapsing-remitting multiple sclerosis receiving subcutaneous interferon β-1a: a Phase II, multicenter, double-blind, randomized, placebo-controlled trial | Q38438519 | ||
| Monthly ambient sunlight, infections and relapse rates in multiple sclerosis | Q39104404 | ||
| Expression of the multiple sclerosis-associated MHC class II Allele HLA-DRB1*1501 is regulated by vitamin D. | Q43197058 | ||
| 25-hydroxyvitamin D in cerebrospinal fluid during relapse and remission of multiple sclerosis | Q43266202 | ||
| Modulation of multiple sclerosis by sunlight exposure: role of cis-urocanic acid | Q43767653 | ||
| High body mass index before age 20 is associated with increased risk for multiple sclerosis in both men and women | Q43865774 | ||
| 25-hydroxyvitamin D and symptomatic ischemic stroke: an original study and meta-analysis | Q44283084 | ||
| Both high and low levels of blood vitamin D are associated with a higher prostate cancer risk: A longitudinal, nested case‐control study in the Nordic countries | Q44656380 | ||
| Sun exposure and vitamin D are independent risk factors for CNS demyelination | Q45028520 | ||
| Smoking as a risk factor for multiple sclerosis | Q45079381 | ||
| Vitamin D and multiple sclerosis: timing of sampling, treatment and prevention. | Q45899674 | ||
| Vitamin A and systemic inflammation as protective factors in multiple sclerosis | Q46105413 | ||
| An action spectrum for the production of cis-urocanic acid in human skin in vivo | Q46457499 | ||
| 1,25-dihydroxyvitamin D exerts similar immunosuppressive effects as UVR but is dispensable for local UVR-induced immunosuppression. | Q47313479 | ||
| A randomised, double blind, placebo controlled trial with vitamin D3 as an add on treatment to interferon β-1b in patients with multiple sclerosis | Q48643059 | ||
| A randomized trial of high-dose vitamin D2 in relapsing-remitting multiple sclerosis | Q48822271 | ||
| Vitamin D as a protective factor in multiple sclerosis. | Q51294922 | ||
| Rare variants in the CYP27B1 gene are associated with multiple sclerosis. | Q55055441 | ||
| Pregnancy and multiple sclerosis (the PRIMS study): clinical predictors of post‐partum relapse | Q56681083 | ||
| Sun exposure and vitamin D are independent risk factors for CNS demyelination | Q58041069 | ||
| Therapeutic Effect of Vitamin D3 in Multiple Sclerosis Patients | Q58121520 | ||
| P433 | issue | 1 | |
| P921 | main subject | multiple sclerosis | Q8277 |
| vitamin D | Q175621 | ||
| P304 | page(s) | 9-18 | |
| P577 | publication date | 2013-12-09 | |
| P1433 | published in | Expert Review of Neurotherapeutics: a key contribution to decision making in the treatment of neurologic and neuropsychiatric disorders | Q15760319 |
| P1476 | title | Vitamin D and multiple sclerosis: where do we go from here? | |
| P478 | volume | 14 |
| Q26778470 | Curbing Inflammation in Multiple Sclerosis and Endometriosis: Should Mast Cells Be Targeted? |
| Q38682352 | Illuminating vitamin D effects on B cells--the multiple sclerosis perspective |
| Q38686389 | Illuminating vitamin D effects on B-cells - the multiple sclerosis perspective |
| Q64249921 | Inflammatory activity and vitamin D levels in an MS population treated with rituximab |
| Q35737941 | Latitude, sun exposure and vitamin D supplementation: associations with quality of life and disease outcomes in a large international cohort of people with multiple sclerosis |
| Q38269727 | Modifiable environmental factors in multiple sclerosis |
| Q36045080 | Vitamin D Status Does Not Affect Disability Progression of Patients with Multiple Sclerosis over Three Year Follow-Up |
| Q47987955 | Vitamin D and axonal injury in multiple sclerosis |
| Q38517185 | Vitamin D and multiple sclerosis—from epidemiology to prevention. |
Search more.